In This Section

HMWG Steering Committee

Kenneth C. Anderson, MD, FAACR
Chair

Kenneth C. Anderson, MD, FAACR

(2024-2027)

Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics
Kraft Family Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Ash A. Alizadeh, MD, PhD

Ash A. Alizadeh, MD, PhD

(2024-2027)

Moghadam Family Professor, Department of Medicine, Division of Oncology and Hematology
Stanford University School of Medicine
Stanford Cancer Institute
Stanford, California

P. Leif Bergsagel, MD

P. Leif Bergsagel, MD

(2024-2027)

Director, Mayo Clinic SPORE in Multiple Myeloma
Co-Director, Hematologic Malignancies Program
Professor of Medicine, Mayo Clinic College of Medicine
Mayo Clinic Cancer Center
Mayo Clinic
Phoenix, Arizona

John C. Byrd, MD

John C. Byrd, MD

(2024-2027)

Department Chair
Gordon and Helen Hughes Taylor Endowed Chair and Professor
University of Cincinnati
Cincinnati, Ohio

Jorge E. Cortes, MD

Jorge E. Cortes, MD

(2024-2027)

Director, Georgia Cancer Center
Professor of Medicine
Cecil F. Whitaker Jr., GRA Eminent Scholar Chair in Cancer
Augusta University
Augusta, Georgia

Riccardo Dalla-Favera, MD, FAACR

Riccardo Dalla-Favera, MD, FAACR

(2024-2027)

Percy and Joanne Uris Professor of Clinical Medicine
Professor of Pathology and Cell Biology, Genetics and Development and Microbiology and Immunology
Director, Institute for Cancer Genetics
Columbia University
New York, New York

Faith E. Davies, MD

Faith E. Davies, MD

(2024-2027)

Director, Center for Blood Disorders
Director, Clinical Myeloma Program
NYU Langone Perlmutter Cancer Center
New York, New York

John E. Dick, PhD, FAACR

John E. Dick, PhD, FAACR

(2024-2027)

Canada Research Chair in Stem Cell Biology
Senior Scientist, Princess Margaret Cancer Centre
University Health Network
Helga and Antonio De Gasperis Chair in Blood Cancer Stem Cell Research
Professor, Department of Molecular Genetics
University of Toronto
Princess Margaret Cancer Centre
Ontario Institute for Cancer Research
Research Institute of the Hospital for Sick Children
Toronto, Ontario

Maria E. Figueroa, MD

Maria E. Figueroa, MD

(2024-2027)

Associate Director, Translational Research
Professor, Biochemistry and Molecular Biology
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Miami, Florida

Christopher R. Flowers, MD, MS

Christopher R. Flowers, MD, MS

(2024-2027)

Division Head ad interim, Division of Cancer Medicine
Chair, Department of Lymphoma and Myeloma
Professor, Department of Lymphoma and Myeloma
UT MD Anderson Cancer Center
Houston, Texas

Margaret A. Goodell, PhD, FAACR

Margaret A. Goodell, PhD, FAACR

(2024-2027)

Professor and Chair, Department of Molecular and Cellular Biology
Director, Stem Cells and Regenerative Medicine Center
Vivian L. Smith Chair of Regenerative Medicine
Baylor College of Medicine
Houston, Texas

Catriona H.M. Jamieson, MD, PhD

Catriona H.M. Jamieson, MD, PhD

(2024-2027)

Director, Sanford Stem Cell Institute
Director, CIRM UC San Diego Alpha Stem Cell Clinic
Professor of Medicine and Chief, Division of Regenerative Medicine
Koman Family Presidential Endowed Chair in Cancer Research
Stanford University
La Jolla, California

Ricky W. Johnstone, PhD

Ricky W. Johnstone, PhD

(2024-2027)

Head, The Sir Peter MacCallum Department of Oncology
Director, Barrie Dalgleish Centre for Multiple Myeloma and Related Blood Cancers
Head, Gene Regulation Laboratory
University of Melbourne
Melbourne, Australia

Anthony G. Letai, MD, PhD

Anthony G. Letai, MD, PhD

(2024-2027)

Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Ross L. Levine, MD

Ross L. Levine, MD

(2024-2027)

Laurence Joseph Dineen Chair in Leukemia Research
Senior Vice President, Translational Research
Member, Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
New York, New York

Ronald Levy, MD, FAACR

Ronald Levy, MD, FAACR

(2024-2027)

Robert K. and Helen K. Summy Professor of Medicine
Stanford University
Stanford, California

Mignon Loh, MD

Mignon Loh, MD

(2024-2027)

Chief, Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy
Professor of Pediatrics
Director, Ben Towne Center for Childhood Cancer Research
Seattle Children’s Hospital
Seattle, Washington

Marcela V. Maus, MD, PhD

Marcela V. Maus, MD, PhD

(2024-2027)

Director of Cellular Immunotherapy
Paula O’Keefe Endowed Chair
Professor of Medicine
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Ari M. Melnick, MD

Ari M. Melnick, MD

(2024-2027)

Director, Sackler Center for Biomedical and Physical Sciences
Laurel Gebroe Family Professor of Hematology and Oncology, Joan and Sanford I. Weill Department of Medicine
and Pharmacology
Weill Cornell Medicine
New York, New York

Ruben A. Mesa, MD

Ruben A. Mesa, MD

(2024-2027)

President, Enterprise Cancer Service Line Atrium Health
Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Enterprise Senior Vice President Atrium Health
Vice Dean for Cancer Programs
The Charles L Spurr MD Professor of Medicine
Wake Forest School of Medicine
Winston-Salem, North Carolina

Joseph Mikhael, MD

Joseph Mikhael, MD

(2024-2027)

Chief Medical Officer, International Myeloma Foundation
Professor, Applied Cancer Research and Drug Discovery Division
Translational Genomics Research Institute
Consultant Hematologist and Director of Myeloma Research
Honor Health Research Institute
Phoenix, Arizona

Philippe Moreau, MD

Philippe Moreau, MD

(2024-2027)

Head, Hematology Department and Early Phase I/II Trials in Clinical Hematology Unit
University Hospital of Nantes
Nantes, France

Nikhil C. Munshi, MD

Nikhil C. Munshi, MD

(2024-2027)

Director of Basic and Correlative Science
Jerome Lipper Multiple Myeloma Center
Kraft Family Chair
Director, Multiple Myeloma Immune Effector Cell Therapy
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Bertrand Nadel, PhD

Bertrand Nadel, PhD

(2024-2027)

Research Director
INSERM
Lab Head, “Genomic Instability and Human Hemopathy”
Centre d’Immunologie de Marseille-Luminy (CIML)
Director
CALYM Carnot Institute
Marseille, France

Seishi Ogawa, PhD

Seishi Ogawa, PhD

(2024-2027)

Professor, Department of Pathology and Tumor Biology
Kyoto University Graduate School of Medicine
Kyoto, Japan

Lilli Petruzzelli, MD, PhD

Lilli Petruzzelli, MD, PhD

(2024-2027)

Senior Vice President, gRED Early Clinical Development
Genentech, Inc.
South San Francisco, California

Charles W.M. Roberts, MD, PhD

Charles W.M. Roberts, MD, PhD

(2024-2027)

Director, Comprehensive Cancer Center
Executive Vice President
St. Jude Children’s Research Hospital
Memphis, Tennessee

Margaret A. Shipp, MD, FAACR

Margaret A. Shipp, MD, FAACR

(2024-2027)

Douglas S. Miller Chair in Hodgkin Lymphoma
Chief, Division of Hematologic Neoplasia
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Kimberly Stegmaier, MD

Kimberly Stegmaier, MD

(2024-2027)

Professor of Pediatrics
Co-director, Pediatric Hematologic Malignancy Program
Boston Children’s Hospital and Dana-Farber Cancer Institute
Ted Williams Chair of Pediatric Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Anas Younes, MD

Anas Younes, MD

(2024-2027)

Senior Vice President, Global Head of Haematology Research and Development
AstraZeneca
New York, New York